𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cross-resistance to alkylating agents in multiple myeloma

✍ Scribed by Joan Bladé; Evarist Feliú; Ciril Rozman; Jordi Estapé; Alfredo Millá; Emili Montserrat

Book ID
101326350
Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
366 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage treatment for patient with multi
Salvage treatment for patient with multiple myeloma refractory to alkylating agents
✍ Gomez, German A. ;Han, Tin ;Ozer, Howard ;Henderson, Edward S. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Sixteen patients with multiple myeloma refractory to alkylating agents were treated with vincristine 0.25 mg/m2 i.v. on days 1 to 4 and prednisone 1 gm/m2 on days 1 and 3. Chemotherapy was repeated every 2 weeks. Of 15 evaluable patients, five achieved a partial response and four stable disease. Thr

Alkylating agents induce activation of N
Alkylating agents induce activation of NFκB in multiple myeloma cells
✍ Philipp Baumann; Sonja Mandl-Weber; Fuat Oduncu; Ralf Schmidmaier 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Multiple myeloma is still not curable and drug combination strategies are currently being evaluated in order to achieve high remission rates with tolerable toxicity. Bortezomib has been shown to exert inhibitory effects on NFB activity. NFB in turn is known to be activated by cytokines, growth facto